Workflow
surgical heart valve solutions
icon
Search documents
Here's What to Expect From Edwards Lifesciences’ Next Earnings Report
Yahoo Finance· 2025-10-06 11:58
Valued at a market cap of $45.2 billion, Edwards Lifesciences Corporation (EW) provides products and technologies to treat advanced cardiovascular diseases. The Irvine, California-based company is best known for its transcatheter aortic valve replacement (TAVR) products under the SAPIEN line, as well as its rapidly growing transcatheter mitral and tricuspid therapies (TMTT) and surgical heart valve solutions. It is scheduled to announce its fiscal Q3 earnings for 2025 after the market closes on Thursday, O ...